Using a multidisciplinary strategy, C. pyrenoidosa protein was investigated as a source of peptides active against ACE and DPP-IV targets, in line with the preclinical and clinical evidences suggesting that the consumption of C. pyrenoidosa may be useful for the prevention of cardiovascular disease. Here, ACE is linked to cardiovascular disorder.